News & Press Releases

CELLERANT THERAPEUTICS, INC. AWARDED $1.5 MILLION SBIR CONTRACT FOR DEVELOPMENT OF NOVEL ANTIBODY-BASED THERAPEUTIC AGAINST IL1RAP
September 26, 2016


CELLERANT THERAPEUTICS, INC. PRESENTS PRECLINICAL DATA SHOWING PROMISE OF A NOVEL DIFFERENTIATED TARGET ON LEUKEMIC STEM CELLS
October 11, 2016


 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.